Search

David A. Sullivan, PhD, in collaboration with colleagues from several institutions worldwide, evaluated the use of recombinant human lubricin – a glycoprotein with lubricating, anti-adhesive and anti-inflammatory activities – as a treatment for patients with dry eye disease. The results of this...

Faculty Recognition Dean Eliott, MD, Evangelos Gragoudas, MD, and Lucia Sobrin, MD, MPH, have been named members of the Ocular Surgery News "Retina 150" list. This is a select group of retinal specialists the editors and publisher have identified as leading innovators in the field of medical and...

NIH and India fund collaborative grant for glaucoma research Boston, Mass. — Researchers from the U.S. and India have begun a new collaborative project to identify genetic risk factors and traits related to glaucoma, a leading cause of blindness worldwide. Funded by the National Eye Institute (NEI)...

Roberto Pineda II, MD, Associate Professor of Ophthalmology, has been accepted into the International Intraocular Implant Club (IIIC). This prestigious society accepts only 250 members worldwide. Founded in 1966, the IIIC supports research and education in the field of intraocular lens implantation...

Congratulations to the Harvard Ophthalmology faculty and alumni who are receiving America Academy Ophthalmology awards for their outstanding contributions to ophthalmology through vision research, education, and service. Laureate Recognition Award The Laureate Recognition Award, the Academy’s single...

A diverse and distinguished group of clinicians and researchers from around the world enjoyed a stimulating two days of active discussion at the first international AMD symposium hosted by the Harvard Ophthalmology. The symposium, which also included leaders from related disciplines outside...

At the fourth Biennial International Symposium on AMD, held October 21-22, 2016 in Boston, more than 200 clinicians, researchers, trainees, and industry representatives discussed current AMD topics and the challenges that lay ahead. One of the central themes of this year’s symposium was the need for...

The second Biennial International Symposium on Ocular Regeneration brought together leaders in the fields of ophthalmology, genetics, stem cell biology, neuroregeneration, and neuroremodeling who aim to accelerate cures for blinding diseases. The event, held October 20, 2016 in Boston, MA, drew...

A phase I/II clinical trial at Massachusetts Eye and Ear found that some patients taking high doses of atorvastatin (cholesterol-lowering medication) had complete resolution of lipid deposits in the dry form of age-related macular degeneration (AMD). AMD is the leading cause of blindness in the...

Joan W. Miller, MD, Henry Willard Williams Professor of Ophthalmology and Chair of the Department of Ophthalmology at Harvard Medical School (HMS), was appointed Treasurer of The Macula Society as of February 27, 2016. Dr. Miller is an internationally recognized expert on retinal disorders...